Home

Jay R. Luly, President and CEO: Enanta Pharmaceuticals ENTA Buy · Filed 25/02/12

Trade details

Type
Insider buy
Amount
$256,050
Shares · price
45,000 sh · $5.69 a share
Held after
846,638 sh
Trade date
25/02/12
Filed
25/02/12
Days to filing
0 days

First buy since 2023

Insiders buying this week
1 insiders
Holding change
+5.6%

Enanta Pharmaceuticals trades, last 26 weeks

What else happened in Enanta Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/01/13~25/03/14

Jay R. Luly's recent trades

  • Jay R. Luly

    SellEnanta Pharmaceuticals

    $67.5K

    Filed 25/12/05

  • Jay R. Luly

    Planned saleEnanta Pharmaceuticals

    $67.5K

    Filed 25/12/05

  • Jay R. Luly

    Sell10b5-1 planEnanta Pharmaceuticals

    $41.4K

    Filed 24/12/10

  • Jay R. Luly

    SellEnanta Pharmaceuticals

    $69.6K

    Filed 23/12/06

  • Jay R. Luly

    SellEnanta Pharmaceuticals

    $709.1K

    Filed 23/03/14